Answers are grounded in this paper and cite their sources.
This editorial discusses cellular and molecular mechanisms of drug resistance in cancer, suggesting implications for treatment strategies.
EditorialCellular and Molecular Mechanisms of Cancer Drug ResistanceMiroslava Matuskova, Andrea BabelovaMiroslava MatuskovaDepartment of Molecular Oncology, Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia and Andrea BabelovaCorresponding author: Andrea Babelova, PhD, Email: [email protected], Department of Nanobiology, Cancer Research Institute, Biomedical Research Center,, Slovak Academy of Sciences, Dubravska cesta 9, 84505 Bratislava, Slovakia, Phone number: +421-2-32295-189Department of Nanobiology, Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, SlovakiaPublished Online:18 Aug 2025https://doi.org/10.1152/ajpcell.00615.2025MoreSections PDF (137 KB) ToolsExport citationAdd to favoritesTrack citations ShareShare onFacebookXLinkedInWeChat Previous Back to Top Next Download PDF FiguresReferencesRelatedInformation More from this issue > Articles in PressPublished 18 Aug 2025 Crossmark Copyright & PermissionsCopyright © 2025 The Authors.Licensed under Creative Commons Attribution CC-BY-NC 4.0. Published by the American Physiological Society.https://doi.org/10.1152/ajpcell.00615.2025PubMed40824851History Received 7 August 2025 Accepted 8 August 2025 Published online 18 August 2025 Keywordscancer drug resistance Metrics
No takes yet. Share an insight, caveat, or question.
Matúšková et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: